Cite
APA Citation
Iede, K., Yamada, T., Kato, R., Ueda, M., Tsuda, Y., Nakashima, S., Ohta, K., Matsuyama, J., Ikenaga, M., & Tominaga, S. (2020). predictive implications of decreased CA19‐9 at 8 weeks during nab‐paclitaxel plus gemcitabine for the induction of second‐line chemotherapy for patients with advanced pancreatic cancer. Cancer reports, 3(6), n/a. http://access.bl.uk/ark:/81055/vdc_100117926555.0x000005